Document Detail


The Endothelin Axis is Upregulated in Human and Rat Right Ventricular Hypertrophy.
MedLine Citation:
PMID:  23233754     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Rationale: Right ventricular (RV) function is the most important determinant of morbidity and mortality in pulmonary arterial hypertension (PAH). Endothelin-1 (ET-1) receptor antagonists (ERAs) are approved therapies for PAH. It is unknown whether ERAs have effects on the RV, in addition to their vasodilating/anti-proliferative effects in pulmonary arteries. Objective: We hypothesized that the endothelin axis is upregulated in RV hypertrophy (RVH) and that ERAs have direct effects on the RV myocardium. Methods and Results: RV myocardial samples from 34 patients with RVH were compared to 16 non-hypertrophied RV samples; and from rats with normal RV versus RVH due to PAH. Confocal immunohistochemistry showed that RVH myocardial endothelin type A (but not type B) receptor and ET-1 protein levels were increased compared to the non-hypertrophied RVs and positively correlated with the degree of RVH (RV thickness/body surface area) (r(2)=0.838 and r(2)=0.818 respectively, p<0.01). These results were recapitulated in the rat model. In modified Langendorff perfusions, ERAs (BQ-123 and bosentan 10(-7,-6,-5M)) decreased contractility in the hypertrophied, but not normal RV, in a dose-dependent manner (p<0.01). Conclusions: Patients and rats with PAH have an up-regulation of the myocardial endothelin axis in RVH. This might be a compensatory mechanism to preserve RV contractility, as the afterload increases. ERAs use might potentially worsen RV function and this could explain some of the peripheral edema noted clinically with these agents. Further studies are required to evaluate the effects of ERA on the RV in patients with RVH and PAH.
Authors:
Jayan Nagendran; Gopinath Sutendra; Ian Paterson; Hunter Champion; Linda J Webster; Brian Chiu; Alois S Haromy; Ivan M Rebeyka; David B Ross; Evangelos D Michelakis
Related Documents :
2982204 - Identification of hydrogen peroxide and hydroxyl radicals as mediators of leukocyte-ind...
10653484 - Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin.
18586514 - Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial ...
19889454 - The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat my...
20484064 - Remote ischemic preconditioning for cerebral and cardiac protection during carotid enda...
19930694 - Left ventricular diastolic dysfunction of the cardiac surgery patient; a point of view ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-10
Journal Detail:
Title:  Circulation research     Volume:  -     ISSN:  1524-4571     ISO Abbreviation:  Circ. Res.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0047103     Medline TA:  Circ Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1University of Alberta, 2D2.18 WMC, 8440-112 St, Edmonton, N/A, T6G2B7, CANADA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In cardiomyocytes, binding of unzipping peptide activates ryanodine receptor 2 and reciprocally inhi...
Next Document:  Profiles in Cardiovascular Science: Shinya Yamanaka - Purveyor of Pluripotency.